Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IDT Australia
Melbourne (Boronia), Victoria, Australia
- Ownership
- Private
- Development stage
- Other
01
Overview
IDT Australia is a commercial-stage CDMO focusing on high-potency and high-containment pharmaceuticals, including mRNA and antibody-drug conjugate manufacturing, with core expertise in oral finished forms, APIs, and complex formulations for both local and global partners[1][3][5].
- Therapeutic areas
- EndocrinologyPsychiatryCardiovascularOncologyNeurology
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugateRNA therapyPsychedelicMedicinal cannabis
- Industry
- Contract Manufacturing Organization
02
Partnerships
Collaborations with universities and research organizationsPharmaceutical/government partners (specific names not listed in current search results)
Beyond the preview
Go deeper on IDT Australia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IDT Australia.